Cozadd Bruce C 的 Form 4 申報
Jazz Pharmaceuticals plc（JAZZ），2022/10/5 申報
- 申報編號
- 0001765581-22-000116
- 申報時間
- 2022/10/5
- 交易日
- 2022/10/3
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 4 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $609.7 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Cozadd Bruce CCIK 0001193210 | 董事、高階主管（董事長、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/10/3 | Ordinary Shares | M行使選擇權取得 | +62,905 | $59.13 | +$3,719,572.65 | 419,213 | 直接 | |
| 2022/10/3 | Ordinary Shares | S賣出處分 | −13,791 | $134.02F2 | −$1,848,269.82 | 405,422 | 直接 | |
| 2022/10/3 | Ordinary Shares | S賣出處分 | −23,646 | $135.18F3 | −$3,196,466.28 | 381,776 | 直接 | |
| 2022/10/3 | Ordinary Shares | S賣出處分 | −7,748 | $135.80F4 | −$1,052,178.4 | 374,028 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/10/3 | Ordinary Shares | M行使選擇權處分 | −62,905 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $133.56 to $134.54. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $134.57 to $135.56. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.57 to $136.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。